Evaluation of learning curve with Indocyanine Green (IcG) versus blue dye for sentinel lymph node biopsy in breast cancer

被引:3
|
作者
Hounschell, Corey A. [1 ]
Kilgore, Lyndsey J. [1 ]
Pruitt, Peggy [2 ]
Wilder, Chloe [2 ]
Balanoff, Christa R. [1 ]
Wagner, Jamie L. [1 ]
Baker, Jordan [3 ]
Chollet-Hinton, Lynn [3 ]
Larson, Kelsey E. [1 ,4 ]
机构
[1] Univ Kansas, Med Ctr, Dept Surg, 4000 Cambridge St, Kansas City, KS 66103 USA
[2] Univ Kansas, Sch Med, 2146 W 39th Ave, Kansas City, KS 66103 USA
[3] Univ Kansas, Med Ctr, Dept Biostat & Data Sci, 3901 Rainbow Blvd, Kansas City, KS 66103 USA
[4] 10700 Nall Ave, Overland Pk, KS 66214 USA
关键词
Sentinel lymph node; Breast cancer; Isosulfan blue; Methylene blue; Indocyanine green; METHYLENE-BLUE; PRACTICE GUIDELINE; FLUORESCENCE;
D O I
10.1016/j.amjsurg.2023.10.003
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Indocyanine green (IcG) is an alternative to isosulfan blue (IB) for sentinel lymph node (SLN) mapping in breast cancer (BC). IcG carries improved cost and safety, but oncologic data upon implementation in practice is limited. We evaluated the learning curve defined as oncologic yield and operative (OR) time for IcG in SLN mapping in BC. Methods: Retrospective review of patients > 18 years with cTis-2 cN0 BC undergoing surgery first with SLN biopsy using IB or IcG. Analysis compared IB versus IcG across three time cohorts. Results: Of 278 patients, 77 received IB and 201 received IcG. OR time was longer for IcG (p = 0.022). There was no difference in oncologic yield between groups (p = 0.35, p = 0.61). Conclusions: Surgeons may be able to safely transition from IB to IcG for patients with early-stage breast cancer undergoing surgery first. Individuals should track their own data to confirm safety of the technique.
引用
收藏
页码:218 / 223
页数:6
相关论文
共 50 条
  • [21] Anaphylactic response to blue dye during sentinel lymph node biopsy
    Bezu, Corinne
    Coutant, Charles
    Salengro, Anne
    Darai, Emile
    Rouzier, Roman
    Uzan, Serge
    SURGICAL ONCOLOGY-OXFORD, 2011, 20 (01): : E55 - E59
  • [22] Green versus blue: Randomized controlled trial comparing indocyanine green with methylene blue for sentinel lymph node detection in endometrial cancer
    Rozenholc, Alexandre
    Samouelian, Vanessa
    Warkus, Thomas
    Gauthier, Philippe
    Provencher, Diane
    Sauthier, Philippe
    Gauthier, France
    Drakopoulos, Panagiotis
    Cormier, Beatrice
    GYNECOLOGIC ONCOLOGY, 2019, 153 (03) : 500 - 504
  • [23] Indocyanine green fluorescence mapping for sentinel lymph node biopsy in early breast cancer
    Pitsinis, Vassilis
    Provenzano, Elena
    Kaklamanis, Loukas
    Wishart, Gordon C.
    Benson, John R.
    SURGICAL ONCOLOGY-OXFORD, 2015, 24 (04): : 375 - 379
  • [24] Indocyanine green combined with methylene blue versus methylene blue alone for sentinel lymph node biopsy in breast cancer: a retrospective study
    Qiu-hui Yang
    Xiang-jian Zhang
    BMC Surgery, 23
  • [25] Sentinel Lymph Node Detection by Blue Dye Versus Indocyanine Green Fluorescence Imaging in Colon Cancer
    Liberale, Gabriel
    Vankerckhove, Sophie
    Galdon, Maria Gomez
    Larsimont, Denis
    Ahmed, Bissan
    Bouazza, Fikri
    Moreau, Michel
    El Nakadi, Issam
    Donckier, Vincent
    Bourgeois, Pierre
    ANTICANCER RESEARCH, 2016, 36 (09) : 4853 - 4858
  • [26] Indocyanine green with methylene blue dye as an alternative to standard dual dye technique for sentinel lymph node biopsy in node-negative early breast cancer: Experience from a tertiary cancer institute
    Bandegudda, Santhoshkumar
    Bindlish, Ridhima
    Naidu, Chandra C. K.
    Mohandas, Anu
    Patel, Rajkumar Pareshbhai
    Kodandapani, Suseela
    Raju, K. V. V. N.
    Thammineedi, Subramanyeshwar R.
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2024, 20 (06) : 1823 - 1830
  • [27] Sentinel lymph node biopsy after neoadjuvant treatment of breast cancer using blue dye, radioisotope, and indocyanine green: Prospective cohort study
    Chirappapha, Prakasit
    Chatmongkonwat, Tanet
    Lertsithichai, Panuwat
    Pipatsakulroj, Wiriya
    Sritara, Chanika
    Sukarayothin, Thongchai
    ANNALS OF MEDICINE AND SURGERY, 2020, 59 : 156 - 160
  • [28] Evaluation of the role of indocyanine green in mapping of axillary sentinel lymph node biopsy
    Salem, Basem G.
    Elfeky, Amr K.
    Abd-erRazik, Mohammad A.
    Abdalla, Gamal M.
    Riad, Amira M.
    Abd Elmoaty, Karim F.
    EGYPTIAN JOURNAL OF SURGERY, 2022, 41 (03) : 1280 - 1286
  • [29] A Randomized Prospective Non-Inferiority Trial of Sentinel Lymph Node Biopsy in Early Breast Cancer: Blue Dye Compared with Indocyanine Green Fluorescence Tracer
    Coibion, Michel
    Olivier, Fabrice
    Courtois, Audrey
    Maes, Nathalie
    Jossa, Veronique
    Jerusalem, Guy
    CANCERS, 2022, 14 (04)
  • [30] Indocyanine green fluorescence method for sentinel lymph node biopsy in breast cancer
    Lin, Joseph
    Lin, Li-Sheng
    Chen, Dar-Ren
    Lin, Kuo-Juei
    Wang, Yu-Fen
    Chang, Yu-Jun
    ASIAN JOURNAL OF SURGERY, 2020, 43 (12) : 1149 - 1153